Specifically, ASA successfully lobbied the Senate Committee on Health, Education, Labor and Pensions to include language in the bill that would require manufacturers to notify the FDA when there is a shortage of a “sterile injectable product” or a drug “used in emergency medical care or during surgery.”
Anesthetic and central nervous system drugs now account for 23 percent of drug shortages nationwide.
Related Articles on Anesthesia:
Stricter Guidelines Needed for Blood Transfusions, Study Says
Anesthesiologist Who Developed Checklist Protocol Receives ABMS Award
Anesthesiologists Are Top Earners in Pennsylvania
